A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection
Clinical trial NCT07141095 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07141095
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-25
- Primary completion
- 2026-10-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.